Many nursing home residents still take antipsychotics, studies find

Share this article:

Antipsychotic medication use is still widespread in nursing homes, even after the federal government issued a “black box” warning on the drugs in 2005. That is according to two new studies.

In one study, researchers examined the number of times the subject of antipsychotics was brought up during doctors' office visits. Between January 2003 and March 2005, mentions grew at a rate of 16% among elderly residents with dementia. In the year after the advisory was issued, mentions dropped by 19% among this group. Researchers found that in 2008, antipsychotic use fell dramatically but still represented 9% of all prescriptions in this population.

Another study found that one-third of residents in nursing homes were prescribed antipsychotics and that one-third of that number did not have dementia or psychosis. The drugs in question include clozapine, risperidone, olanzapine and paliperidone. Doctors prescribe these drugs, which are designed to treat bipolar disorder and schizophrenia, off-label for residents with dementia. Both studies appeared in Monday's issue of the Archives of Internal Medicine.


Share this article:

More in News

CMS expands therapy payment research

The government is expanding its research into alternative therapy payments, to consider more holistic changes to the way Medicare reimburses skilled nursing facilities, the Centers for Medicare & Medicaid Services announced Tuesday.

CDC tightens Ebola guidelines for healthcare workers

The Centers for Disease Control and Prevention has issued more stringent guidelines for how healthcare workers should interact with Ebola patients, following an outcry from nurses and other professionals.

Nonprofit providers face alarming market forces, must rally, LeadingAge chairman says

Nonprofit providers face alarming market forces, must rally, ...

Nonprofit long-term care providers must work together to address alarming trends, or their market share could plummet and the sector as a whole could falter, LeadingAge Chairman David Gehm told ...